resolver

Seyam, M.S., Freshwater, D.A., O'Donnell, K., Mutimer, D.J. (2005). Weight loss
during pegylated interferon and ribavirin treatment of chronic hepatitis C. J Viral
Hepat. 12, 531-535
Smith, G.P., Gibbs, J. (1985). The satiety effect of cholecystokinin. Recent progress
and current problems. Ann N Y Acad Sci. 448, 417-23
Suwantarat, N., Tice, A.D., Khawcharoenporn, T., Chow, D.C. (2010). Weight loss,
leukopenia and thrombocytopenia associated with sustained virologic response to
Hepatitis C treatment. Int J Med Sci. 7, 36-42
Suzuki, F., Suzuki, Y., Akuta, N., Sezaki, H., Yatsuji, H., Arase, Y., Hirakawa, M.,
Kawamura, Y., Hosaka, T., Kobayashi, M., Saito, S., Ikeda, K., Kobayashi, M.,
Watahiki, S., Mineta, R., Iwasaki, S., Kumada, H. (2010). Sustained virological
response in a patient with chronic hepatitis C treated by monotherapy with the NS3-
4A protease inhibitor telaprevir. J Clin Virol. 47, 76-78
Tahan, V., Karaca, C., Yildirim, B., Bozbas, A., Ozaras, R., Demir, K., Avsar, E.,
Mert, A., Besisik, F., Kaymakoglu, S., Senturk, H., Cakaloglu, Y., Kalayci, C.,
Okten, A., Tozun, N. (2005). Sexual transmission of HCV between spouses. Am J
Gastroenterol. 100, 821-824.
Tatemoto, K., Mutt, V. (1980). Isolation of two novel candidate hormones using a
chemical method for finding naturally occurring polypeptides. Nature 285, 417-8
Testino, G., Sumberaz, A., Ancarani, A.O., Borro, P., Ravetti, G., Ansaldi, F.,
Andorno, E., Gentile, R., Icardi, G. (2009). Influence of body mass index,
cholesterol, triglycerides and steatosis on pegylated interferon alfa-2a and ribavirin
treatment for recurrent hepatitis C in patients transplanted for HCV and alcoholic
cirrhosis. Hepatogastroenterology 56, 501-503
Tschöp, M., Smiley, D.L., Heiman, M.L. (2000). Ghrelin induces adiposity in
rodents. Nature 407, 908-913
83